Please login to the form below

Not currently logged in
Email:
Password:

Medicare

This page shows the latest Medicare news and features for those working in and with pharma, biotech and healthcare.

Lilly joins new Medicare scheme to reduce insulin prices

Lilly joins new Medicare scheme to reduce insulin prices

The drugmaker will partake in the new ‘Senior Savings Model’, which aims to improve the affordability of insulin for seniors enrolled in Medicare Part D. ... insulins. According to Lilly, of the proportion of people paying over $100 per prescription

Latest news

More from news
Approximately 5 fully matching, plus 155 partially matching documents found.

Latest Intelligence

  • The US celebrates five years of biosimilars on the market – a look to the past, present and future The US celebrates five years of biosimilars on the market – a look to the past, present and future

    Between 2012 and 2016, annual spending on biologic drugs in the US nearly doubled, with unit prices accounting for 56% of the spending increase within Medicare Part D and 20% in ... In Medicare Part B, legislation could be passed to encourage physician

  • Eliminating pharmaceutical rebates, is this déjà vu? Eliminating pharmaceutical rebates, is this déjà vu?

    Due to consolidation in the industry, most prescription drug benefits, including Medicare Part D benefits, are administered by several significant PBMs. ... Completely eliminating Medicare Part D rebates within PBMs is not essential for lowering the

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    2020. It seeks to incentivise drug developers by changing the way Medicare reimburses hospitals for treating patients with bacterial infections.

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    Others call for more involvement from equally relevant and powerful government bodies, such as Congress, the Centers for Medicare and Medicaid Services, the US Patent and Trademark Office and the US

  • The Golden Goose The Golden Goose

    Yet another market-friendly idea that enjoys broad support among patient advocacy groups is allowing Medicare to negotiate with drugmakers. ... Unfortunately, on closer inspection, this pathway also presents difficulties. To negotiate effectively,

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...

Infographics